This is Archived Content

This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA). Find the latest information on substance use, health, and NIDA research at

Cite this article

NIDA. (2014, February 4). Medication may help patients with severe mental illness stay smoke-free. Retrieved from

press ctrl+c to copy

Science Spotlight

February 04, 2014

Smokers with schizophrenia or bipolar disorders are three times more likely to abstain from smoking over the course of a year if they take varenicline.

Although varenicline is an FDA-approved smoking cessation medication, it had not been proven effective for smokers with severe mental illness. The results of this study suggest that it is feasible to prescribe varenicline to these patients, which could lessen the health burdens caused by smoking in this population.

For a copy of the study abstract (published online January 8), go to: For facts on drug abuse in patients with have mental illness, go to

For more information, contact the NIDA press office at or 301-443-6245.

Picture of a health lung and a tobacco smokers blackened lung